Fig. 4From: Insulin-like growth factor-I serum levels and their biological effects on Leishmania isolates from different clinical forms of American tegumentary leishmaniasisIGF-I serum levels in patients with American Tegumentary Leishmaniasis. Serum of patients with CL (n=65), ML (n=20), DL (n=29), and healthy subjects were measured by chemiluminescent immunometric assay (IMMULITE® 2000-DPC). The horizontal bar represents the median value. Kruskal-Wallis test with the Dunn contrast post-test: *CL in relation to DL; Controls in relation to DL and ML P < 0.05; **CL in relation to ML P < 0.001Back to article page